GSK plc (LON:GSK)
London · Delayed Price · Currency is GBP · Price in GBX 1,880.50
+22.50 (1.21%)
At close: Jan 14, 2026
GSK plc Market Cap
GSK plc has a market cap or net worth of 75.45 billion as of January 14, 2026. Its market cap has increased by 37.32% in one year.
Market Cap
75.45B
Enterprise Value
89.50B
Revenue
32.17B
Ranking
n/a
PE Ratio
14.15
Stock Price
1,880.50
Market Cap Chart
Since December 27, 2000, GSK plc's market cap has increased from 64.68B to 75.45B, an increase of 16.65%. That is a compound annual growth rate of 0.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 74.55B | 1.84% |
| Dec 31, 2025 | 73.20B | 33.23% |
| Dec 31, 2024 | 54.94B | -7.05% |
| Dec 29, 2023 | 59.11B | 1.25% |
| Dec 30, 2022 | 58.38B | -27.44% |
| Dec 31, 2021 | 80.46B | 20.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 218.99B |
| Haleon | 32.26B |
| Smith & Nephew | 10.66B |
| Convatec Group | 4.76B |
| Hikma Pharmaceuticals | 3.47B |
| HUTCHMED (China) | 1.93B |
| Genus | 1.72B |
| Oxford Nanopore Technologies | 1.49B |